March Cancer Awareness Month: Colorectal, Kidney Cancer, and Multiple Myeloma — HuMOLYTE March honors Colorectal Cancer Awareness Month, Kidney Cancer Awareness Month, and Multiple Myeloma Awareness Month. Read a supportive blog for patients and caregivers on awareness, early action, and ...

March is a time to raise awareness for Colorectal Cancer Awareness Month, Kidney Cancer Awareness Month, and Multiple Myeloma Awareness Month.

#ColorectalCancerAwarenessMonth #KidneyCancerAwarenessMonth #MultipleMyelomaAwarenessMonth #CancerAwareness #Caregivers #PatientSupport

March is #MultipleMyelomaAwarenessMonth. AACR Project GENIE offers valuable insights into the genomic landscape of multiple myeloma, with 1,167 patients and 1,548 sequenced tumor samples. #AACRGENIE: www.aacr.org/professional... Powering the future of precision oncology.

When Kellie was diagnosed with multiple myeloma, her husband, Yaphet “wanted to do anything to help find a cure.” He decided to participate in #StandUpToCancer’s clinical trial, THE PROMISE Study. Read more: bit.ly/43A2X1B. #MultipleMyelomaAwarenessMonth

UCLA scientists develop novel technology that positions ‘off-the-shelf’ cancer immunotherapy for the clinic Immunotherapies have revolutionized cancer treatment by harnessing the body’s own immune system to attack cancer cells and halt tumor growth. However, these therapies often need to be tailored to each...

This #MultipleMyelomaAwarenessMonth, learn about how center scientist Dr. Lili Yang is developing a new treatment approach using CAR-iNKT cells that could improve patient outcomes.

Multiple Myeloma: Improved Prognosis With the Latest Treatments Learn how multiple myeloma prognosis has improved significantly with the emergence of new drug treatments.

This #MultipleMyelomaAwarenessMonth, read about @szusmani.bsky.social's vision for developing new treatment approaches at MSK that will improve #mm outcome: bit.ly/3DAzQkt

So it’s March, which means it’s #MultipleMyelomaAwarenessMonth… unless, of course, you have #multiplemyeloma. Then, every month is Multiple Myeloma Awareness Month. Whee!

In honor of #MultipleMyelomaAwarenessMonth 🩸, get to know our active #myeloma trials! EAA181/EQUATE is a randomized phase 3 trial for newly diagnosed #MultipleMyeloma patients. Learn more here: bit.ly/eaa181equate #mmsm cc: @vincentrk.bsky.social

CU Cancer Center researchers and physicians are world leaders in blood cancers like multiple myeloma and the best in the Rocky Mountain region for stem cell transplant outcomes.

Learn more about multiple myeloma: buff.ly/4kbuEnk

#MultipleMyelomaAwarenessMonth